CMAC 2023; 25(4) | CMAC

CMAC 2023; 25(4)

Mycoplasma pneumoniae is a common etiologic agent of respiratory tract infections and communityacquired pneumonia (CAP) in children and …

Objective. To analyze the characteristics of patients with severe COVID-19 and lethal outcome. Materials and Methods. This …

This paper presents the first clinical case of combined pulmonary and abdominal M. genavense infection in an otherwise healthy, …

The purpose of the expert council was to determine the place of cefpodoxime in the ABT algorithms for upper and lower respiratory tract …

Objective. To determine in vitro activity of oral III generation cephalosporin cefpodoxime against clinical isolates of Haemophilus …

The steadily increasing incidence of invasive fungal infections, influenced to some extent by the COVID-19 pandemic, caused by both …

Objective. To assess the dynamics of antimicrobial drug consumption in the Russian Federation. Materials and Methods. Data on …

Objective. To assess the effects of chromosomal mutations on emergence of cefiderocol resistance among Pseudomonas aeruginosa clinical …

Objective. To compare results of microbiological examination obtained on rapid automated system with semiquantitative plate culture to …

Objective. To study significance of herpesviruses in the development of infectious complications in patients after heart …

Objective. To conduct a comparative evaluation of the results of phenotypic and molecular genetic methods for testing drug resistance …

Objective. To develop the method for determining the viability of M. leprae using polymerase chain reaction to evaluate the …